Showing results (1301-1310 of 2,709) with videos related to

Sort By:
Pageof 271
The Lancet. Infectious Diseases|June 19, 2023
Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort studyDan-Yu Lin, Yangjianchen Xu, Yu Gu, et al.
The Lancet. Infectious Diseases|June 16, 2023
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trialBernhards Ogutu, Adoke Yeka, Sylvia Kusemererwa, et al.
The Lancet. Infectious Diseases|June 23, 2023
Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series studyDan Yamin, Matan Yechezkel, Ronen Arbel, et al.
The Lancet. Infectious Diseases|March 27, 2026
Double-dose azithromycin mass drug administration, facial cleanliness, and fly control measures for trachoma control in Oromia, Ethiopia (Stronger SAFE): a cluster-randomised controlled trialAnna Last, Oumer Shafi Abdurahman, Katie Greenland, et al.
The Lancet. Infectious Diseases|April 5, 2026
Immunogenicity of high-dose recombinant influenza vaccine versus standard-dose egg-grown and cell-grown vaccines among frequently and infrequently vaccinated young adults in Singapore: a randomised, controlled, double-blind, single-centre, phase 4 clinical trialSheena G Sullivan, Xuan Ying Poh, Stephany Sanchez-Ovando, et al.
The Lancet. Infectious Diseases|May 1, 2026
Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trialAdam J Ritchie, Omary Hassan, Nsiande Urasa, et al.
The Lancet. Infectious Diseases|March 20, 2026
Na-GST-1 adsorbed on Alhydrogel co-administered with different Toll-like receptor agonists in hookworm-naive adults using a controlled human infection model in the USA: a phase 2, double-blind, randomised controlled trialCaroline K DiRosato, Elissa M Malkin, Sean M Lee, et al.
The Lancet. Infectious Diseases|March 19, 2026
Evaluating dengue transmission dynamics in an endemic urban setting in Viet Nam: an index-household contact cohort studyLucy Masdin, James Ashall, Mai Kim Huynh, et al.
The Lancet. Infectious Diseases|April 20, 2026
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry studyAnnalisa Paviglianiti, Per Ljungman, Rafael de la Camara, et al.
The Lancet. Infectious Diseases|May 19, 2026
Global and regional molecular epidemiology of HIV-1 during 1990-2024: systematic review, global survey, and analysis of prevalenceAyisha Khalid, Lucy Gettins, Lauren Scullion, et al.
Pageof 271